{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:56:52Z","timestamp":1769057812468,"version":"3.49.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,20]]},"abstract":"<jats:p>Portal vein thrombosis (PVT) is a common thrombotic complication of cirrhosis. It can lead to variceal bleeding and bowel ischemia and also complicate liver transplantation. Identifying the possible risk factors associated with PVT can aid in identifying patients at high risk, enabling their screening and potentially preventing PVT through the rational use of anticoagulants. This study focuses on examining the clinical characteristics of PVT in cirrhotic patients and identifying the clinical and biochemical factors that are linked to the development of PVT. Consecutive hospitalized cirrhotic patients between 2015 and 2023 were identified through the hospital\u2019s computerized medical records based on the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) coding system and retrospectively analyzed. 928 individuals were included in this study; 783 (84.3%) without PVT and 145 (15.7%) with benign PVT. Hepatitis B virus (HBV) was significantly more common in the PVT group (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.02), while alcohol and primary sclerosing cholangitis (PSC) were less common in this group (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.01 and .02, respectively). Hepatocellular carcinoma (HCC) (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005&lt;\u2005.01), ascites (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.01), and spontaneous bacterial peritonitis (SBP) (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.02) were more common in the PVT group. Patients with PVT had a higher international normalized ratio (INR) level (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.042) and lower plasma albumin (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.01). No differences were identified in white blood cell, hemoglobin, platelet, and bilirubin levels. However, patients with PVT had higher model for end-stage liver disease (MELD) (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.01) and Child-Pugh scores (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u2005=\u2005.03). This study demonstrated a higher likelihood of PVT presence in cirrhotic patients with advanced age, HBV, and HCC, along with ascites, SBP, splenomegaly, hypoalbuminemia, elevated INR, and a higher MELD score. Nevertheless, additional research endeavors are necessary to accurately ascertain and validate supplementary risk factors within a broader demographic.<\/jats:p>","DOI":"10.1097\/md.0000000000039823","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T16:00:55Z","timestamp":1727107255000},"page":"e39823","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and predictors of benign portal vein thrombosis in patients with liver cirrhosis: A retrospective single-center study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-1278","authenticated-orcid":false,"given":"Erfan","family":"Arabpour","sequence":"first","affiliation":[{"name":"Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Pasharavavesh","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hassan","family":"Rabbani","sequence":"additional","affiliation":[{"name":"Department of Transplant and Hepatobiliary Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Zarean Shahraki","sequence":"additional","affiliation":[{"name":"Department of Health Information Technology and Management, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Amiri","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1134801","DOI":"10.3389\/fmed.2023.1134801","article-title":"Portal vein thrombosis in cirrhosis: a literature review.","volume":"10","author":"Prakash","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.","volume":"104","author":"Pan","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis.","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"R5-20250503","first-page":"315","article-title":"Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.","volume":"31","author":"Mantaka","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.3390\/jcm11216435","article-title":"Portal vein thrombosis in the setting of cirrhosis: a comprehensive review.","volume":"11","author":"Odriozola","year":"2022","journal-title":"J Clin Med"},{"key":"R7-20250503","first-page":"375","article-title":"Etiology and complications of portal vein thrombosis.","volume":"30","author":"Trebicka","year":"2014","journal-title":"Viszeralmedizin"},{"key":"R8-20250503","article-title":"Liver transplant in patients with portal vein thrombosis: the experience of 55 patients.","volume":"8","author":"Ozer","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/apt.13019","article-title":"portal vein obstruction\u2013epidemiology, pathogenesis, natural history, prognosis and treatment.","volume":"41","author":"Kumar","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1665-2681(19)30797-5","article-title":"Portal vein thrombosis: what is new?","volume":"14","author":"del Carmen Manzano-Robleda","year":"2015","journal-title":"Ann Hepatol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"100998","DOI":"10.1016\/j.blre.2022.100998","article-title":"Gut dysbiosis, endotoxemia and clotting activation: a dangerous trio for portal vein thrombosis in cirrhosis.","volume":"57","author":"Violi","year":"2023","journal-title":"Blood Rev"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Hemostasis in cirrhosis: understanding destabilising factors during acute decompensation.","volume":"78","author":"Zanetto","year":"2023","journal-title":"J Hepatol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajg.2014.08.003","article-title":"Procoagulant versus anticoagulant factors in cirrhotic patients.","volume":"15","author":"El Bokl","year":"2014","journal-title":"Arab J Gastroenterol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/s-0040-1713169","article-title":"Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis.","volume":"120","author":"Campello","year":"2020","journal-title":"Thromb Haemost"},{"key":"R15-20250503","first-page":"e23785","article-title":"Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management.","volume":"14","author":"Islam","year":"2022","journal-title":"Cureus"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.","volume":"27","author":"Abdel-Razik","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23 796 consecutive autopsies.","volume":"12","author":"\u00d6gren","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases.","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation.","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"100482","DOI":"10.1016\/j.xkme.2022.100482","article-title":"Venous excess Doppler ultrasound for the nephrologist: pearls and pitfalls.","volume":"4","author":"Koratala","year":"2022","journal-title":"Kidney Med"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jceh.2014.12.008","article-title":"Portal vein thrombosis.","volume":"5","author":"Chawla","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"R22-20250503","first-page":"3189","article-title":"The risk factors of portal vein thrombosis in patients with liver cirrhosis.","volume":"17","author":"Cagin","year":"2019","journal-title":"Exp Ther Med"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation.","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-11-66","article-title":"High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.","volume":"11","author":"Lertpipopmetha","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novoportal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes.","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"17562848221087536","DOI":"10.1177\/17562848221087536","article-title":"Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case\u2013control study.","volume":"15","author":"Wang","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MEG.0000000000001774","article-title":"Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis.","volume":"32","author":"Wang","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R28-20250503","first-page":"260","article-title":"A single hospital study on portal vein thrombosis in cirrhotic patients-clinical characteristics & risk factors.","volume":"139","author":"Chen","year":"2014","journal-title":"Indian J Med Res"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"100535","DOI":"10.1016\/j.aohep.2021.100535","article-title":"From Child-Pugh to MELD score and beyond: taking a walk down memory lane.","volume":"27","author":"Ruf","year":"2022","journal-title":"Ann Hepatol"},{"key":"R30-20250503","first-page":"991","article-title":"The risk of thrombotic events in patients with liver cirrhosis.","volume":"116","author":"G\u00eerleanu","year":"2012","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors.","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"10.15761\/JTS.1000182","DOI":"10.15761\/JTS.1000182","article-title":"Hemostasis, bleeding and thrombosis in liver disease.","volume":"3","author":"Flores","year":"2017","journal-title":"J Transl Sci"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4251\/wjgo.v16.i4.1213","article-title":"Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers.","volume":"16","author":"Nie","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/07853890.2022.2028893","article-title":"A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.","volume":"54","author":"Xing","year":"2022","journal-title":"Ann Med"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnut.2020.00032","article-title":"Alcohol consumption and risk for venous thromboembolism: a meta-analysis of prospective studies.","volume":"7","author":"Chen","year":"2020","journal-title":"Front Nutr"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1160\/TH07-07-0470","article-title":"Alcohol consumption is associated with a decreased risk of venous thrombosis.","volume":"99","author":"Pomp","year":"2008","journal-title":"Thromb Haemost"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/MEG.0000000000001624","article-title":"Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort.","volume":"32","author":"Fan","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","article-title":"International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.","volume":"18","author":"Olivera","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.crohns.2011.10.003","article-title":"Portal vein thrombosis in inflammatory bowel diseases: a single-center case series.","volume":"6","author":"Maconi","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R41-20250503","first-page":"e26407","article-title":"Risk factors for portal vein thrombosis in patients with cirrhosis awaiting liver transplantation in Shiraz, Iran.","volume":"15","author":"Lankarani","year":"2015","journal-title":"Hepat Mon"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis.","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12072-019-09951-6","article-title":"Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.","volume":"13","author":"Xu","year":"2019","journal-title":"Hepatol Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:43:37Z","timestamp":1746319417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":43,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039823","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}